Annual Accounts Payable
$2.18 M
-$18.60 K-0.84%
September 30, 2024
Summary
- As of February 6, 2025, SONN annual accounts payable is $2.18 million, with the most recent change of -$18.60 thousand (-0.84%) on September 30, 2024.
- During the last 3 years, SONN annual accounts payable has fallen by -$1.60 million (-42.26%).
- SONN annual accounts payable is now -54.06% below its all-time high of $4.75 million, reached on September 30, 2022.
Performance
SONN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.18 M
+$304.40 K+16.20%
September 30, 2024
Summary
- As of February 6, 2025, SONN quarterly accounts payable is $2.18 million, with the most recent change of +$304.40 thousand (+16.20%) on September 30, 2024.
- Over the past year, SONN quarterly accounts payable has increased by +$304.40 thousand (+16.20%).
- SONN quarterly accounts payable is now -54.06% below its all-time high of $4.75 million, reached on September 30, 2022.
Performance
SONN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SONN Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.8% | +16.2% |
3 y3 years | -42.3% | +16.2% |
5 y5 years | +18.5% | +16.2% |
SONN Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -54.1% | at low | -54.1% | +31.9% |
5 y | 5-year | -54.1% | +18.5% | -54.1% | +31.9% |
alltime | all time | -54.1% | +18.5% | -54.1% | +31.9% |
Sonnet BioTherapeutics Holdings Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $2.18 M(-0.8%) | $2.18 M(+16.2%) |
Jun 2024 | - | $1.88 M(+7.2%) |
Mar 2024 | - | $1.75 M(+5.9%) |
Dec 2023 | - | $1.66 M(-24.8%) |
Sep 2023 | $2.20 M(-53.7%) | $2.20 M(-27.2%) |
Jun 2023 | - | $3.02 M(-32.8%) |
Mar 2023 | - | $4.50 M(-1.6%) |
Dec 2022 | - | $4.57 M(-3.8%) |
Sep 2022 | $4.75 M | $4.75 M(+57.4%) |
Jun 2022 | - | $3.02 M(-25.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $4.04 M(+91.1%) |
Dec 2021 | - | $2.11 M(-44.1%) |
Sep 2021 | $3.78 M(+83.8%) | $3.78 M(+75.8%) |
Jun 2021 | - | $2.15 M(+12.4%) |
Mar 2021 | - | $1.91 M(-15.3%) |
Dec 2020 | - | $2.26 M(+9.8%) |
Sep 2020 | $2.06 M(+11.6%) | $2.06 M(-15.0%) |
Jun 2020 | - | $2.42 M(-47.7%) |
Mar 2020 | - | $4.63 M |
Sep 2019 | $1.84 M | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual accounts payable?
- What is the all time high annual accounts payable for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual accounts payable year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly accounts payable year-on-year change?
What is Sonnet BioTherapeutics Holdings annual accounts payable?
The current annual accounts payable of SONN is $2.18 M
What is the all time high annual accounts payable for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual accounts payable is $4.75 M
What is Sonnet BioTherapeutics Holdings annual accounts payable year-on-year change?
Over the past year, SONN annual accounts payable has changed by -$18.60 K (-0.84%)
What is Sonnet BioTherapeutics Holdings quarterly accounts payable?
The current quarterly accounts payable of SONN is $2.18 M
What is the all time high quarterly accounts payable for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly accounts payable is $4.75 M
What is Sonnet BioTherapeutics Holdings quarterly accounts payable year-on-year change?
Over the past year, SONN quarterly accounts payable has changed by +$304.40 K (+16.20%)